Literature DB >> 2889058

Modified trimethoprim-sulphamethoxazole doses in Pneumocystis carinii pneumonia.

I McLean, C R Lucas, M L Mashford, P J Harman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2889058     DOI： 10.1016/s0140-6736(87)91046-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Pneumocystis carinii, an opportunist in immunocompromised patients.

Authors:  M S Bartlett; J W Smith
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

2.  Variability of serum concentrations of trimethoprim and sulfamethoxazole during high dose therapy.

Authors:  J Blaser; B Joos; M Opravil; R Lüthy
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

3.  Serum peak sulfamethoxazole concentrations demonstrate difficulty in achieving a target range: a retrospective cohort study.

Authors:  Bao D Dao; Jason N Barreto; Robert C Wolf; Ross A Dierkhising; Matthew F Plevak; Pritish K Tosh
Journal:  Curr Ther Res Clin Exp       Date:  2014-11-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.